Cardinal Capital Management Buys 10,463 Shares of National Research Co. (NASDAQ:NRC)

Cardinal Capital Management boosted its holdings in National Research Co. (NASDAQ:NRC) by 63.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,988 shares of the company’s stock after purchasing an additional 10,463 shares during the quarter. Cardinal Capital Management owned approximately 0.11% of National Research worth $1,072,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in NRC. Gladius Capital Management LP raised its holdings in National Research by 59.8% during the 4th quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after buying an additional 496 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in National Research by 184.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock valued at $126,000 after purchasing an additional 2,061 shares in the last quarter. SG Americas Securities LLC bought a new stake in National Research during the fourth quarter valued at about $147,000. Portside Wealth Group LLC raised its stake in National Research by 11.9% in the fourth quarter. Portside Wealth Group LLC now owns 5,238 shares of the company’s stock valued at $207,000 after buying an additional 555 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its stake in National Research by 22.3% in the fourth quarter. BNP Paribas Financial Markets now owns 11,479 shares of the company’s stock valued at $454,000 after buying an additional 2,095 shares during the last quarter. 47.26% of the stock is currently owned by institutional investors.

National Research Trading Down 0.0 %

National Research stock opened at $22.99 on Friday. National Research Co. has a one year low of $22.75 and a one year high of $47.25. The stock has a market cap of $549.00 million, a PE ratio of 18.54 and a beta of 0.56. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.41 and a current ratio of 0.41. The stock has a 50-day moving average of $29.50 and a two-hundred day moving average of $35.73.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.27 earnings per share (EPS) for the quarter. National Research had a return on equity of 54.83% and a net margin of 20.60%. The firm had revenue of $35.31 million during the quarter.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Friday, June 28th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.09%. The ex-dividend date of this dividend is Friday, June 28th. National Research’s payout ratio is 38.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.